Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs

  title={Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs},
  author={Joo H. Lee and Yong-Jun Shin and Ju-Hee Oh and Young-Joo Lee},
  journal={Archives of Pharmacal Research},
In this study, we investigated pharmacokinetic drug interactions of clopidogrel with P-gp inhibitors in rats and dogs. Following the oral administration of clopidogrel with or without the P-gp inhibitors, quercetin (250 mg/kg), telmisartan (8 mg/kg), and cyclosporine A (10 mg/kg), in rats and dogs, the plasma concentration-time profiles of clopidogrel carboxylic acid, a surrogate marker for the bioavailability of clopidogrel, were determined. Co-administration of the quercetin, telmisartan and… 

Impaired liver cytochrome P450 2C11 activity after dual antiplatelet therapy with aspirin and clopidogrel in rats

Results demonstrated that DAPT led to minimal impact on aspirin esterase activity but significant decrease in rCyp2c11 activity and mRNA expression, which could provide guidance on its safe clinical use with other CYP 2C19 substrates.

Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity

The primary mechanism of RSV–CP DDI can be attributed to the inhibition of intestinal BCRP by CP combined with the inhibited of hepatic B CRP by CPC, which is likely to be more clinically relevant and be a contributing factor for increased hepatotoxicity in the presence of DDI.

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy

Effective and safe clopidogrel combination therapy can be achieved by increasing the awareness of potential changes in efficacy and toxicity, rationally selecting alternatives, tailoring drug therapy based on genotype, checking the appropriateness of physician orders, and performing therapeutic monitoring.

In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1.

Clopidogrel drug interactions: a review of the evidence and clinical implications

Most studies assessing the clinical implications of clopidogrel–drug interactions have not shown to significantly affect outcomes, however, awareness of these DDIs remains important for optimizing the selection of concomitant therapies.

P-Glycoprotein: A Focus on Characterizing Variability in Cardiovascular Pharmacotherapeutics

C cautious monitoring of drug's level and eventually dose adjustment might be necessary to avoid drug–drug interactions, failure of therapy, or drug toxicity; especially with the use of drugs that possess narrow therapeutic index like digoxin.

Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications.

This review focuses on the expression and function of the major transport proteins expressed in species of veterinary interest, and their impact on drug disposition, efficacy and toxicity.

A Simple UPLC/MS-MS Method for Simultaneous Determination of Lenvatinib and Telmisartan in Rat Plasma, and Its Application to Pharmacokinetic Drug-Drug Interaction Study

Lenvatinib is a multi-targeted tyrosine kinase inhibitor that inhibits tumor angiogenesis, but hypertension is the most common adverse reaction. Telmisartan is an angiotensin receptor blocker used to

Drug Bioavailability Enhancing Agents of Natural Origin (Bioenhancers) that Modulate Drug Membrane Permeation and Pre-Systemic Metabolism

The aim of this paper is to provide an overview of natural bioenhancers and their main mechanisms of action for the nasal, buccal, pulmonary and oral routes of drug administration.



Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats

It is indicated that cyclosporin A could be effective in inhibiting the efflux of atorvastatin, and itraconazole could beeffective in inhibition of both the metabolism and biliary excretion of atorsportatin.

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.

Concomitant administration of rifampin reduced digoxin plasma concentrations substantially after oral administration but to a lesser extent after intravenous administration, and induction of intestinal P-gp could explain this new type of drug-drug interaction.

Pharmacokinetic interaction between telithromycin and metformin in diabetes mellitus rats

  • J. H. LeeH. KangM. Lee
  • Biology, Medicine
    Xenobiotica; the fate of foreign compounds in biological systems
  • 2010
After the oral and intravenous administration of both drugs together, the total area under the plasma concentration–time curve (AUC) of metformin was comparable possibly due to the increased intestinal metabolism of met formin by telithromycin.

Comparison of formation of thiolactones and active metabolites of prasugrel and clopidogrel in rats and dogs

The extent of in vivo formation of the thiolactone and the active metabolite of prasugrel was greater than for clopidogrel’s thiolactsone and active metabolites, which demonstrates that these products are generated in the intestine during the absorption process.

Modest Effect of Impaired P-glycoprotein on the Plasma Concentrations of Fexofenadine, Quinidine, and Loperamide following Oral Administration in Collies

It is suggested that P-gp limits the intestinal absorption of fexofenadine in dogs, and the Mdr1 mutation will be useful for examining the effect of P- gp on the oral availability of drugs.

Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently

CYP3A4 and CYP3A5 inhibition by ketoconazole affects formation of clopidogrel's but not prasugrel's active metabolite, which is associated with reduced IPA.

The Effect of Telmisartan on the Steady‐State Pharmacokinetics of Digoxin in Healthy Male Volunteers

Although there was some evidence for a pharmacokinetic interaction between digoxin and telmisartan found in this study, the safety and tolerability of digoxin were unaffected by concurrent administration of tel Misartan in the study population.

Intra-herb pharmacokinetics interaction between quercetin and isorhamentin

P-gp might play an important role, whereas other drug efflux pumps, such as multi-drug resistance associate protein 2 and breast cancer resistance protein, might be involved in the cell efflux of isorhamnetin.